ArticleOncoTargets and therapy2018

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.

Hongtuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.